92 related articles for article (PubMed ID: 2068152)
21. Prognostic significance of cell proliferation in human neuroblastoma: comparison with other prognostic factors.
Mejía C; Navarro S; Pellín A; Ruíz A; Castel V; Llombart-Bosch A
Oncol Rep; 2003; 10(1):243-7. PubMed ID: 12469176
[TBL] [Abstract][Full Text] [Related]
22. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
23. Metastatic ganglioneuroma: a misnomer.
DasGupta S; Das RN; Mishra PK; Chatterjee U; Datta C
Indian J Pathol Microbiol; 2014; 57(3):445-6. PubMed ID: 25118741
[TBL] [Abstract][Full Text] [Related]
24. Molecular detection of GAGE expression in peripheral blood and bone marrow: utility as a tumor marker for neuroblastoma.
Cheung IY; Cheung NK
Clin Cancer Res; 1997 May; 3(5):821-6. PubMed ID: 9815755
[TBL] [Abstract][Full Text] [Related]
25. [Bilateral adrenal pheochromocytoma. Diagnosis and follow-up using the clonidine test and measurement of plasma neuropeptide Y concentration].
Eisenhut S; Rascher W; Lang RE
Monatsschr Kinderheilkd; 1990 Sep; 138(9):631-4. PubMed ID: 2233767
[TBL] [Abstract][Full Text] [Related]
26. Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa.
Baranowska B; Wolinska-Witort E; Wasilewska-Dziubinska E; Roguski K; Chmielowska M
Neuro Endocrinol Lett; 2001 Oct; 22(5):356-8. PubMed ID: 11600878
[TBL] [Abstract][Full Text] [Related]
27. [Plasma neuropeptide Y (NPY) levels in patients with gastric and colorectal carcinomas].
Li Y; Chen S; Li Z
Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):213-5. PubMed ID: 10921011
[TBL] [Abstract][Full Text] [Related]
28. Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumors.
Cohen PS; Cooper MJ; Helman LJ; Thiele CJ; Seeger RC; Israel MA
Cancer Res; 1990 Sep; 50(18):6055-61. PubMed ID: 2393870
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
[TBL] [Abstract][Full Text] [Related]
30. Neuroblastoma. A review of the experience at The Medical College of Virginia (1957-1968).
Valdes OS; Maurer HM; Shumway CN
Va Med Mon (1918); 1970 Jun; 97(6):340-4. PubMed ID: 5528112
[No Abstract] [Full Text] [Related]
31. Neuroblastoma in children, 42 cases.
Hinton P; Buschke F
Radiol Clin Biol; 1968; 37(1):19-28. PubMed ID: 5667683
[No Abstract] [Full Text] [Related]
32. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
33. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
[TBL] [Abstract][Full Text] [Related]
34. Cholinergic regulation of neuropeptide Y synthesis and release in human neuroblastoma cells.
Dozio E; Ruscica M; Feltrin D; Motta M; Magni P
Peptides; 2008 Mar; 29(3):491-5. PubMed ID: 18155321
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of neuroblastoma: analysis of a single institution.
Izbicki T; Mazur J; Izbicka E
Anticancer Res; 2003; 23(2C):1933-8. PubMed ID: 12820482
[TBL] [Abstract][Full Text] [Related]
36. [Intrathoracic tumors of the sympathetic nervous system--characteristics of their biological behavior].
Anders M; Lorenz G; Reddemann H
Padiatr Grenzgeb; 1988; 27(6):503-9. PubMed ID: 3237421
[No Abstract] [Full Text] [Related]
37. The International Neuroblastoma Pathology Classification (the Shimada system).
Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP
Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273
[TBL] [Abstract][Full Text] [Related]
38. [Factors affecting the prognosis of neuroblastomas in children].
Ionov AA
Vopr Onkol; 1983; 29(6):53-6. PubMed ID: 6346677
[TBL] [Abstract][Full Text] [Related]
39. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
[TBL] [Abstract][Full Text] [Related]
40. Functional expression of neuropeptide Y receptors in human neuroblastoma cells.
Li AJ; Ritter S
Regul Pept; 2005 Jul; 129(1-3):119-24. PubMed ID: 15927706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
